Zolymbus Gel
Product Images NDC 82584-010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Zolymbus (NDC 82584-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Thea Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zolymbus 01)

FDA Label Image

Ifu Step 3 (Zolymbus 02)

FDA Label Image

Ifu Step 4 (Zolymbus 03)

FDA Label Image

Ifu Step 5-6-7 (Zolymbus 04)

FDA Label Image

Logo (Zolymbus 05)

FDA Label Image

Carton (Zolymbus 06)

Carton (Zolymbus 06)
ZOLYMBUS™ is a bimatoprost ophthalmic gel containing 0.01% bimatoprost. It is for topical ophthalmic use and comes in single-dose containers. The gel is designed for ophthalmic use and should only be used as directed. This product is prescription-only and contains active ingredient bimatoprost.*
FDA Label Image

Pouch (Zolymbus 07)

Pouch (Zolymbus 07)
This is information regarding a medication with the NDC number 82584-010-81. The recommended dosage is to apply one drop in the affected eye(s) once daily in the evening from a single-dose container. Once opened, the foil pouch can be used for up to 14 days, then discard any unused containers after 14 days. The medication is ZOLYMBUS™, a bimatoprost ophthalmic gel with a concentration of 0.01%. It is for topical ophthalmic use and comes in 10 single-dose containers. The product does not contain preservatives and should be stored between 20-30°C.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.